Gelernter, Joel

Department of Genetics, Yale University School of Medicine, West Haven, CT, USA

Title	Year	PMID
Author Correction: Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction.	2025	39643700
Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder.	2025	40360802
Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. preprint	2025	38712091
Multi-ancestral genome-wide association study of clinically defined nicotine dependence reveals strong genetic correlations with other substance use disorders and health-related traits.	2025	40831304
Multi-ancestral genome-wide association study of clinically defined nicotine dependence reveals strong genetic correlations with other substance use disorders and health-related traits. preprint	2025	39974067
Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder.	2024	38637617
Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes.	2024	38632388
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses.	2023	37464041
Discovery of 95 PTSD loci provides insight into genetic architecture and neurobiology of trauma and stress-related disorders. preprint	2023	37693460
Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals.	2023	38062264
Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders.	2023	37250466
Exploring the genetic overlap between twelve psychiatric disorders.	2022	36471075
Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond.	2022	36207451
The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates.	2022	34750568
Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions.	2021	34045744
Genetics of substance use disorders in the era of big data.	2021	34211176
Genome-wide association analyses of post-traumatic stress disorder and its symptom subdomains in the Million Veteran Program.	2021	33510476
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology.	2021	34002096
Genome-wide association study of phenotypes measuring progression from first cocaine or opioid use to dependence reveals novel risk genes.	2021	34124712
Genome-wide association study of stimulant dependence.	2021	34226506

Affiliation
Veteran Affairs CT Healthcare System, West Haven, CT, USA.
Veterans Affairs Connecticut Healthcare Center, West Haven, Connecticut joel.gelernter@yale.edu.
Veterans Affairs Connecticut Healthcare Center, West Haven, CT, USA.
Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut.
Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.
Veterans Affairs Connecticut Healthcare System, West Haven, CT, 06516, USA.
Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA. joel.gelernter@yale.edu.
Veterans Affairs (VA) Connecticut Healthcare Center, New Haven.
Yale School of Medicine, New Haven, Connecticut.
Yale School of Medicine, New Haven, CT, 06511, USA.
Yale School of Medicine, New Haven, CT, USA.
Yale University School of Medicine, Department of Genetics and Neuroscience, New Haven, CT, USA.
Yale University School of Medicine, Department of Psychiatry, Division of Human Genetics; and VA CT Healthcare Center, West Haven, CT 06516, USA. joel.gelernter@yale.edu

Gelernter, Joel

Resolved affiliation